Vita 34 AG
XETRA:V3V
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
DE |
Vita 34 AG
XETRA:V3V
|
74.4m EUR | 7.1 | ||
US |
Cigna Corp
NYSE:CI
|
98.7B USD | 4.7 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
91.3B EUR | 4.7 | |
US |
CVS Health Corp
NYSE:CVS
|
68.7B USD | 2.2 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 5.4 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 5.9 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 4.2 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 5.1 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.3B EUR | 4.2 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 128.5 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.